BioSino Bio-technology and Science Inc operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares BioSino Bio-technology and Science Inc with three other
companies in this sector in China:
Guangdong Hybribio Biotech Co Ltd
sales of 479.09 million Chinese Renmimbi [US$70.80 million]
of which 97%
was Monitoring Instrument),
Getein Biotech Inc
(488.58 million Chinese Renmimbi [US$72.20 million]
of which 99%
was In-vitro diagnostics), and
(302.89 million Chinese Renmimbi [US$44.76 million]
of which 94%
was Reagent Income).
BioSino Bio-technology and Science Inc reported sales of 295.13 million Chinese Renmimbi (US$43.61 million)
December of 2017.
decrease of 9.3%
versus 2016, when the company's sales were 325.39 million Chinese Renmimbi.